Literature DB >> 1693584

Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG).

K R Durrant1, C Mangioni, A J Lacave, M George, M E van der Burg, D Guthrie, N Rotmenz, O Dalesio, J B Vermorken.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693584     DOI: 10.1016/0090-8258(90)90367-t

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  6 in total

Review 1.  Drug therapy for gynaecological cancer in older women.

Authors:  R E van Rijswijk; J B Vermorken
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

Review 2.  "Unresectable" vulval cancers: is neoadjuvant chemotherapy the way forward?

Authors:  Kathryn Graham; Kevin Burton
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

3.  Therapy for Primary Vulvar Carcinoma.

Authors:  D Herr; I Juhasz-Boess; E F Solomayer
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-03       Impact factor: 2.915

Review 4.  Chemotherapy of vulvar cancer: a review.

Authors:  Gunter Deppe; Ismail Mert; Jimmy Belotte; Ira S Winer
Journal:  Wien Klin Wochenschr       Date:  2013-03-22       Impact factor: 1.704

Review 5.  Electrochemotherapy in Vulvar Cancer and Cisplatin Combined with Electroporation. Systematic Review and In Vitro Studies.

Authors:  Anna Myriam Perrone; Gloria Ravegnini; Stefano Miglietta; Lisa Argnani; Martina Ferioli; Eugenia De Crescenzo; Marco Tesei; Marco Di Stanislao; Giulia Girolimetti; Giuseppe Gasparre; Anna Maria Porcelli; Francesca De Terlizzi; Claudio Zamagni; Alessio Giuseppe Morganti; Pierandrea De Iaco
Journal:  Cancers (Basel)       Date:  2021-04-21       Impact factor: 6.639

6.  Clinical analysis of neoadjuvant chemotherapy in patients with advanced vulvar cancer: A STROBE-compliant article.

Authors:  Yizhen Niu; Rutie Yin; Danqing Wang; Qingli Li; Xiu Gao; Meimei Huang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.